Vous êtes ici :Accueil
/
Équipes
/
Durantel D - HepVir
/
Quoi de neuf pour nous ?
/
Loss of hepatitis D virus infectivity upon farnesyl transferase inhibitor treatment associates with increasing RNA editing rates revealed by a new RT-ddPCR method
Info
Loss of hepatitis D virus infectivity upon farnesyl transferase inhibitor treatment associates with increasing RNA editing rates revealed by a new RT-ddPCR method
Verrier et al., Antiviral Research, 2022 / Team HepVir
